Wall Street Expects 9% Upside Potential for UnitedHealth Stock

Analysts’ views on UnitedHealth Group

UnitedHealth Group (UNH) is one of the largest Fortune 500 companies. It’s the largest health insurer in the United States. The company operates across two divisions: UnitedHealthcare and Optum. In this part of the series, we’ll look at analysts’ recommendations for UNH stock.

Wall Street Expects 9% Upside Potential for UnitedHealth Stock

As of September 24, according to a Reuters survey of 24 analysts covering UNH stock, ten analysts have recommended a “strong buy,” and 13 have recommended a “buy.” Only one analyst has recommended a “hold.” None of the analysts have rated the stock a “sell.”

Target prices

According to these analysts, the consensus target price for UNH stock is $290.62. That represents a return of ~8.7% for the next 12 months based on UNH’s closing price of $267.36 on September 24.

Analysts’ average target prices for peers Aetna (AET), Cigna (CI), and Anthem (ANTM) are $203.73, $225.61, and $299.05, respectively. Those target prices imply 12-month return potentials of 0.16%, 11%, and 9.5%, respectively.